Main Article Content
Phytochemicals from that Celastrus paniculatus plant extract can be used to cure skin diseases. It is caused by Staphylococcus aureus. “Molecular docking method” of the phytochemicals with the enzyme was studied using “Biovia Discovery Studio”. “High positive values of -CDOCKER energy and -CDOCKER interaction energy” suggested that the phytochemicals alkaloids, stearic acid, betacyperonethe (benzene), and polyalcohol (ethanol) can effectively deactivate the L-lactate dehydrogenase enzyme thereby interrupting the life cycle of Staphylococcus aureus.
Silva GL, Lee IS, Kinghorn AD. Special problems with the extraction of plants. In Natural Products Isolation. 1998;343-363. Humana Press.
Ahmad F, Khan RA, Rasheed S. Preliminary screening of methanolic extracts of Celastrus paniculatus and Tecomella undulata for analgesic and anti-inflammatory activities. Journal of Ethnopharmacology. 1994;42(3):193-198.
Satyavati GV, Raina MK, Sharma M. Medicinal plants of India. Indian Council of Medical Research; 1987.
Moran GJ, Amii RN, Abrahamian FM, Talan DA. Methicillin-resistant Staphylococcus aureus in community-acquired skin infections. Emerging Infectious Diseases. 2005;11(6):928.
Koehn FE, Carter GT. The evolving role of natural products in drug discovery. Nature Reviews Drug Discovery. 2005;4(3):206-220.
Kalam MA, Khanday S, Salim S, Nida K, Ahmad A. Malkangni (Celastrus paniculatus Willd.): Neuropharmacological properties in perspective of unani medicine and pharmacological studies-a review; 2018.
Grayson ML. The treatment triangle for staphylococcal infections; 2006.
Debnath M, Pushpan R, Kumari H, Nishteswar K. Medico ethnobotanical perspectives of jyotismati (Celastrus paniculatus Willd)-a herbal tranquilizer. Journal of Drug Delivery and Therapeutics. 2012;2(3).
Serhan CN, Chiang N, Van Dyke TE. Resolving inflammation: Dual anti-inflammatory and pro-resolution lipid mediators. Nature Reviews Immunology. 2008;8(5):349-361.
Lowy FD. Staphylococcus aureus infections. N. Engl. J. Med; 1998.
Rasigade JP, Vandenesch F. Staphylococcus aureus: A pathogen with still unresolved issues. Infection, Genetics and Evolution. 2014;21:510-514.
Harris A, Torres-Viera C, Venkataraman L, DeGirolami P, Samore M, Carmeli Y. Epidemiology and clinical outcomes of patients with multiresistant Pseudomonas aeruginosa. Clinical Infectious Diseases. 1999;28(5):1128-1133.
Tong SY, Davis JS, Eichenberger E, Holland TL, Fowler VG. Staphylococcus aureus infections: Epidemiology, pathophysiology, clinical manifestations, and management. Clinical Microbiology Reviews. 2015;28(3):603-661.
Liu F, Fritsche HA, Trujillo JM, Samuels ML. Serum lactate dehydrogenase isoenzyme 1 in patients with advanced testicular cancer. American Journal of Clinical Pathology. 1982;78(2):178-183.
Collins FM, Lascelles J. The effect of growth conditions on oxidative and dehydrogenase activity in Staphylococcus aureus. Microbiology. 1962;29(3):531- 535.
Brinda OP, Mathew D, Shylaja MR, Davis PS, Cherian KA, Valsala PA. Isovaleric acid and avicequinone-C are Chikungunya virus resistance principles in Glycosmis pentaphylla (Retz.) Correa. Journal of Vector Borne Diseases. 2019;56(2):111.